
Sophie HanSophieHan
Partner, Life Sciences & Healthcare
Sophie Han is a partner in the Litigation Department of Paul Hastings. Her practice focuses on cross-border corporate transactions, outbound and inbound investment matters and mergers and acquisitions in China. Sophie is also experienced in compliance matters relating to FCPA and China compliance regulations, handling internal investigations, government enforcement actions, and proactive reviews.
Sophie received a Bachelor of Laws (LL.B.) from Shanghai International Studies University in 2007 and a Master of Laws (LL.M.) from Stanford Law School in 2012. She passed the Chinese bar in 2007 but does not hold a current practicing certificate.
Stanford Law School, LL.M., 2012
Shanghai International Studies University, LL.B., 2007
Advised Huayi Brothers, a Chinese multinational entertainment company, on the US$30 million convertible note investment by Tencent, a Chinese internet-based technology and cultural enterprise.
Advised CDH Genetech Limited, part of the CDH Investments group, in its US$1.4 billion agreement to acquire all the issued shares of Sirtex Medical Limited, an Australian medical device company, through a Scheme of Arrangement.
- “Next Generation Partner” – Corporate M&A: Foreign Firms
Legal 500 China
- “Rising Stars,”
China Business Law Journal